Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Operating Leases (2020 - 2025)

Historic Operating Leases for KORU Medical Systems (KRMD) over the last 6 years, with Q3 2025 value amounting to $2.7 million.

  • KORU Medical Systems' Operating Leases fell 2314.32% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year decrease of 2314.32%. This contributed to the annual value of $3.0 million for FY2024, which is 1006.79% down from last year.
  • According to the latest figures from Q3 2025, KORU Medical Systems' Operating Leases is $2.7 million, which was down 2314.32% from $2.8 million recorded in Q2 2025.
  • KORU Medical Systems' 5-year Operating Leases high stood at $4.2 million for Q2 2022, and its period low was $24033.0 during Q2 2021.
  • For the 5-year period, KORU Medical Systems' Operating Leases averaged around $3.0 million, with its median value being $3.5 million (2024).
  • Its Operating Leases has fluctuated over the past 5 years, first surged by 1733823.08% in 2022, then plummeted by 2314.32% in 2025.
  • Quarter analysis of 5 years shows KORU Medical Systems' Operating Leases stood at $95553.0 in 2021, then soared by 4085.21% to $4.0 million in 2022, then dropped by 16.57% to $3.3 million in 2023, then decreased by 10.07% to $3.0 million in 2024, then dropped by 10.4% to $2.7 million in 2025.
  • Its last three reported values are $2.7 million in Q3 2025, $2.8 million for Q2 2025, and $2.9 million during Q1 2025.